Note dell’episodio
The 2026 HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma guideline, highlighting key recommendations and good practice statements across testing methods, the use immunohistochemistry with subsequent in-situ hybridization, specimen collection, and more.
• HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
• American Society for Clinical Pathology (ASCP) / College of American Pathologists (CAP)
• October 21, 2026
• Guideline Summary: https://www.guidelinecentral.com/guideline/24275/
• Full-Text…
Sito web: podcasters.spotify.com

